Welcome to our dedicated page for Cardinal Health news (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.
Cardinal Health (CAH) generates news primarily around quarterly earnings reports, distribution contract announcements, and strategic acquisitions that expand its pharmaceutical and medical products reach. As one of the nation's largest healthcare distributors, the company's business developments signal broader trends in pharmaceutical supply chain economics, hospital purchasing patterns, and healthcare cost management.
The company's news flow typically includes earnings releases that reveal pharmaceutical distribution volume trends and medical segment margin performance. These reports provide insights into generic drug pricing dynamics, specialty pharmaceutical growth, and hospital capital spending patterns. Cardinal Health also announces distribution agreements with pharmacy chains and hospital group purchasing organizations, contracts that can shift significant market share within the concentrated wholesale industry.
Acquisition announcements represent another significant news category, as Cardinal Health periodically purchases specialty distributors, medical product manufacturers, or technology companies to expand service capabilities. These deals often target higher-margin businesses in specialty pharmaceuticals, nuclear medicine, or at-home healthcare services that complement the company's core distribution operations. Facility expansion news, including new distribution centers and manufacturing plants, indicates capacity investments responding to customer demand shifts.
Regulatory developments also generate material news for Cardinal Health, particularly regarding opioid distribution litigation, drug pricing legislation, or supply chain security requirements. The company faces ongoing legal proceedings related to controlled substance distribution oversight, and settlement announcements or regulatory compliance updates can significantly impact investor sentiment. Following Cardinal Health news provides visibility into both company-specific operational trends and broader pharmaceutical industry economics affecting the entire healthcare distribution sector.
Cardinal Health (NYSE: CAH) will report second-quarter fiscal 2026 results on February 5, 2026, prior to the opening of trading on the New York Stock Exchange. The company will host a webcast discussion beginning at 8:30 a.m. Eastern.
Investors can access the live webcast and slide presentation through Cardinal Health's Investor Relations page with no access code required. Presentation slides and a replay will remain available on the Investor Relations page for 12 months.
Cardinal Health (NYSE: CAH) announced a quarterly cash dividend of $0.5107 per share, declared from the company's capital surplus.
The dividend is payable on January 15, 2026 to shareholders of record at the close of business on January 2, 2026.
Cardinal Health (NYSE: CAH) completed its acquisition of Solaris Health on November 3, 2025, adding the country's leading urology MSO to its MSO platform.
Solaris Health brings more than 750 providers across 250+ practice locations in 14 states, expanding the Urology Alliance and increasing Cardinal Health's MSO reach to approximately 3,000 providers in 32 states.
Cardinal Health (NYSE: CAH) reported Q1 FY2026 revenue of $64.0 billion, up 22% year‑over‑year, with GAAP operating earnings of $668 million (+18%) and GAAP diluted EPS of $1.88 (+11%). Non‑GAAP operating earnings rose 37% to $857 million and non‑GAAP diluted EPS increased 36% to $2.55. The company raised FY2026 non‑GAAP EPS guidance to $9.65–$9.85 (+17%–20%) and adjusted free cash flow to $3.0–$3.5 billion. Cardinal expects to complete the acquisition of Solaris Health in early November and initiated a $375 million accelerated share repurchase program.
Cardinal Health (NYSE: CAH) has announced plans to build a new 230,000-square-foot flagship forward distribution center in Indianapolis, Indiana. The state-of-the-art facility will feature an industry-first robotic storage and retrieval system, developed in partnership with Swisslog.
The facility will enhance Cardinal Health's pharmaceutical distribution network, which currently handles over 70,000 pharmaceutical and specialty deliveries daily. Key features include real-time inventory visibility, intelligent order fulfillment, and advanced robotics. The center is expected to be fully operational by fall 2027 and will create more than 100 new jobs in Indiana.
Cardinal Health (NYSE: CAH) has scheduled the release of its first-quarter fiscal 2026 financial results for October 30, 2025, before the NYSE market opening. The company will host a webcast discussion of the results at 8:30 a.m. Eastern.
Investors can access the webcast and accompanying slide presentation through Cardinal Health's Investor Relations page without requiring an access code. The presentation materials and webcast replay will remain available on the IR page for 12 months following the event.
Cardinal Health (NYSE: CAH) has unveiled its new 350,000-square-foot Consumer Health Logistics Center in Groveport, Ohio. The state-of-the-art facility serves as a centralized replenishment hub for distributing over-the-counter medications and healthcare products to over 20 forward distribution centers nationwide.
The facility, operational since July 2025, features advanced automation including robotics, automated labeling, and high-speed conveyors. It has created 150 new jobs and represents part of Cardinal Health's broader investment strategy, which includes $115 million invested in Ohio over the past five years for four new distribution centers and infrastructure improvements.
Cardinal Health (NYSE: CAH) announced significant expansion of its at-Home Solutions distribution network with the opening of a new 340,000 square foot facility in Fort Worth, Texas, and plans for a new distribution center in Sacramento, California. The Texas facility, capable of shipping 10,000 packages daily, marks the third distribution center built in three years, adding over 750,000 square feet to the network.
The company's at-Home Solutions business serves more than 6 million people annually in the United States, providing critical medical supplies for chronic conditions. The new Sacramento facility is expected to be operational by Summer 2027. Additionally, Cardinal Health will upgrade its Ontario, California facility with automated systems to enhance efficiency.
Cardinal Health (NYSE: CAH) has announced that its Board of Directors has approved a quarterly dividend of $0.5107 per share. The dividend will be paid from the company's capital surplus and is scheduled for payment on October 15, 2025 to shareholders of record as of October 1, 2025.
Cardinal Health (NYSE: CAH) reported strong Q4 FY2025 results with revenue flat at $60.2 billion but up 21% excluding a contract expiration impact. Q4 non-GAAP operating earnings increased 19% to $719 million, with non-GAAP EPS up 13% to $2.08.
For FY2025, the company achieved $222.6 billion in revenue and non-GAAP operating earnings growth of 15% to $2.8 billion. Notably, Cardinal Health raised its FY2026 non-GAAP EPS guidance to $9.30-$9.50, representing 13-15% growth.
The company announced the acquisition of Solaris Health, the leading urology MSO with over 750 providers, and delivered strong performance across all five operating segments, each growing profit by double-digits. FY2025 adjusted free cash flow reached $2.5 billion.
FAQ
What is the current stock price of Cardinal Health (CAH)?
What is the market cap of Cardinal Health (CAH)?
